Clinical Trials Browser

Phase 2 × Lymphoma × Interleukin-2 × Clear all

NCT00994643 2025-04-30

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

11 enrolled 9 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT01700946 2022-09-28

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Phase 2 Completed

80 enrolled 13 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma